Cancer immunology research

CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.

Cancer immunology research

Du J, Lopez-Verges S, Pitcher BN, Johnson J, Jung SH, Zhou L, Hsu K, Czuczman MS, Cheson B, Kaplan L, Lanier LL, Venstrom JM

NKG2D Receptor and Its Ligands in Host Defense.

Cancer immunology research

Lanier LL

Pages